 | Issue navigator |
|
|
Contents of Volume 11 Suppl 1
Abstracts of the Ninth International Congress on Drug Therapy in HIV Infection
Meeting abstracts  A single PDF containing all abstracts in this Supplement is available here.
from Ninth International Congress on Drug Therapy in HIV Infection
Glasgow, UK. 9 13 November 2008
|
Keynote presentation
Pathogenesis of HIV infection: implications for treatment and prevention
HC Lane
Journal of the International AIDS Society 2008, 11(Suppl 1):K1 (10 November 2008)
[Abstract] [Full text] [PDF] [PubMed] [Related articles]
Keynote presentation
How will we use the new ART drugs?
C Katlama
Journal of the International AIDS Society 2008, 11(Suppl 1):K2 (10 November 2008)
[Abstract] [Full text] [PDF]
Keynote presentation
The implications beyond public health if we don't manage the HIV epidemic
A Whiteside
Journal of the International AIDS Society 2008, 11(Suppl 1):K3 (10 November 2008)
[Abstract] [Full text] [PDF]
Oral presentation
O111 Global impact of HIV drug resistance
D Pillay
Journal of the International AIDS Society 2008, 11(Suppl 1):O1 (10 November 2008)
[Abstract] [Full text] [PDF]
Oral presentation
O112 Trends in transmitted HIV drug resistance among non-B subtypes in the UK
D Chilton, L Harrison, H Green, S Lattimore, V Delpech, D Pillay
Journal of the International AIDS Society 2008, 11(Suppl 1):O2 (10 November 2008)
[Abstract] [Full text] [PDF]
Oral presentation
O113 HIV-1 clade C resistance genotypes after first virological failure in a large community ART programme
C Orrell, RP Walensky, E Losina, KA Freedberg, R Wood
Journal of the International AIDS Society 2008, 11(Suppl 1):O3 (10 November 2008)
[Abstract] [Full text] [PDF]
Oral presentation
O114 NNRTI mutations are efficiently transmitted within clusters of new HIV infections
BG Brenner, T d'Aquin Toni, M Roger, JP Routy, D Moisi, MA Wainberg
Journal of the International AIDS Society 2008, 11(Suppl 1):O4 (10 November 2008)
[Abstract] [Full text] [PDF]
Oral presentation
O115 Importance of detecting minority variants in the clinical management of HIV
D Kuritzkes
Journal of the International AIDS Society 2008, 11(Suppl 1):O5 (10 November 2008)
[Abstract] [Full text] [PDF]
Oral presentation
O121 Drug interactions that really matter
SH Khoo
Journal of the International AIDS Society 2008, 11(Suppl 1):O6 (10 November 2008)
[Abstract] [Full text] [PDF]
Oral presentation
O122 Prevalence of drug interactions between antiretroviral and co-administered drugs at the Moi teaching and referral hospital (Ampath), Eldoret, Kenya
GK Kigen, S Kimaiyo, DJ Back, SE Gibbons, E Sang, IG Edwards, A Owen, SH Khoo
Journal of the International AIDS Society 2008, 11(Suppl 1):O7 (10 November 2008)
[Abstract] [Full text] [PDF]
Oral presentation
O123 To overdose or underdose? The question of Kaletra in children in the UK/Irish Collaborative HIV Paediatric Study (CHIPS)
AS Walker, KL Boyd, K Doerholt, H Lyall, E Menson, K Butler, P Tookey, A Riordan, D Shingadia, A Judd, G Tudor-Williams, DM Gibb
Journal of the International AIDS Society 2008, 11(Suppl 1):O8 (10 November 2008)
[Abstract] [Full text] [PDF]
Oral presentation
O124 Efavirenz and rifampicin in the South African context: is there a need to dose increase efavirenz with concurrent rifampicin therapy?
C Orrell, K Cohen, P Ive, I Sanne, R Wood
Journal of the International AIDS Society 2008, 11(Suppl 1):O9 (10 November 2008)
[Abstract] [Full text] [PDF]
Oral presentation
O125 Impact of efavirenz and nevirapine on pharmacokinetics of lopinavir/ritonavir as tablets and capsules in African patients
C Kityo, AS Walker, F Lutwana, F Ssali, R Nalumenya, D Tumukunde, J Kawiya, P Munderi, A Reid, CF Gilks, DM Gibb, SH Khoo
Journal of the International AIDS Society 2008, 11(Suppl 1):O10 (10 November 2008)
[Abstract] [Full text] [PDF]
Oral presentation
O132 Secondline ART in the developing world
J Hakim
Journal of the International AIDS Society 2008, 11(Suppl 1):O11 (10 November 2008)
[Abstract] [Full text] [PDF]
Oral presentation
O131 Where are we with National and International guidelines?
E Katabira
Journal of the International AIDS Society 2008, 11(Suppl 1):O12 (10 November 2008)
[Abstract] [Full text] [PDF]
Oral presentation
O135 Seek and treat for optimal prevention of HIV/AIDS (STOP HIV/AIDS)
JSG Montaner
Journal of the International AIDS Society 2008, 11(Suppl 1):O13 (10 November 2008)
[Abstract] [Full text] [PDF]
Oral presentation
O133 HIV/TB: when is it safe to start HAART?
R Wood
Journal of the International AIDS Society 2008, 11(Suppl 1):O14 (10 November 2008)
[Abstract] [Full text] [PDF]
Oral presentation
O134 HIV disease management and challenges in Eastern Europe and Central Asia
A Bobrik
Journal of the International AIDS Society 2008, 11(Suppl 1):O15 (10 November 2008)
[Abstract] [Full text] [PDF]
Oral presentation
O211 HIV and the brain: neuro-inflammation long-term, CNS control of HIV replication, brain disease in suppressed patients and differential penetration of drugs
D Clifford
Journal of the International AIDS Society 2008, 11(Suppl 1):O16 (10 November 2008)
[Abstract] [Full text] [PDF]
Oral presentation
O212 Rate of change in CD4 counts in patients with stable HIV viremia
AN Phillips, B Ledergerber, JR Bogner, K Lacombe, A Wiercinska-Drapalo, P Reiss, O Kirk, JD Lundgren, A Mocroft
Journal of the International AIDS Society 2008, 11(Suppl 1):O17 (10 November 2008)
[Abstract] [Full text] [PDF]
| |
|   |
